You have 9 free searches left this month | for more free features.

BTKi

Showing 1 - 25 of 53

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

BTK Inhibitors-related AF Treated by Catheter Ablation

Not yet recruiting
  • BTKi-induced Atrial Fibrillation
  • +2 more
  • Atrial fibrillation catheter ablation in a population of BTKi-induced atrial fibrillation
  • Caen, Normandy, France
    Caen University Hospital
Nov 10, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • BTK inhibitor
  • PD-1 inhibitor
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023

REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy

Not yet recruiting
  • CLL, Relapsed
  • +3 more
    • Clermont-Ferrand, France
    • +7 more
    Nov 16, 2022

    Relapsed Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Italy (Consolidation with ADCT-402 (loncastuximab

    Recruiting
    • Relapsed Mantle Cell Lymphoma
    • Refractory Mantle Cell Lymphoma
    • Consolidation with ADCT-402 (loncastuximab tesirine) after salvage immunochemotherapy (R-BAC, Rituximab - Bendamustine, Ara-C))
    • Brescia, Italy
    • +19 more
    Apr 22, 2022

    Relapsed/Refractory Trial in Santa Fe (Tafasitamab, Lenalidomide, Tazemetostat)

    Recruiting
    • Relapsed/Refractory
    • Santa Fe, California
      California Cancer Associates For Research And Excellence, cCARE
    Feb 23, 2022

    Lymphocytic Leukemia, Chronic, Lymphoma, Small Lymphocytic Trial in Canada, United States (IPI-145 (duvelisib), Obinutuzumab)

    Terminated
    • Lymphocytic Leukemia, Chronic
    • Lymphoma, Small Lymphocytic
    • La Jolla, California
    • +6 more
    Mar 15, 2021

    PICAROS - Acalabrutinib RWE on 1L CLL in Spain

    Recruiting
    • Chronic Lymphocytic Leukemia
      • Almeria, Andalucia, Spain
      • +36 more
      Aug 10, 2023

      Cardiac Arrhythmias in Subjects Treated With BTK Inhibitors

      Recruiting
      • Chronic Lymphocytic Leukemia (CLL)
      • +5 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Feb 16, 2023

        B-cell Malignancies Undergoing Treatment With Bruton Tyrosine

        Not yet recruiting
        • Chronic Lymphocytic Leukemia
        • +4 more
        • Non-Interventional Study
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Nov 22, 2023

        Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

        Completed
        • Leukemia, Lymphocytic, Chronic, B-Cell
        • +2 more
        • Tafasitamab
        • +2 more
        • Jacksonville, Florida
        • +16 more
        Dec 10, 2021

        Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (Duvelisib)

        Withdrawn
        • Chronic Lymphocytic Leukemia
        • Small Lymphocytic Lymphoma
        • Tempe, Arizona
        • +7 more
        Mar 15, 2021

        Chronic Lymphocytic Leukemia, CLL Progression, CLL/SLL Trial in New York (Umbralisib, Ublituximab)

        Recruiting
        • Chronic Lymphocytic Leukemia
        • +2 more
        • New York, New York
          Weill Cornell Medicine
        Mar 29, 2022

        B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)

        Recruiting
        • B-cell Non Hodgkin Lymphoma
        • regimen with BTK inhibitor +Anti-CD19 CAR T cells
        • Xuzhou, Jiangsu, China
          The Affiliated Hospital of Xuzhou Medical University
        Feb 23, 2023

        Waldenstrom Macroglobulinemia Trial in Tianjin (Zanubrutinib, Bendamustine and Rituximab)

        Recruiting
        • Waldenstrom Macroglobulinemia
        • Zanubrutinib, Bendamustine and Rituximab
        • Tianjin, Tianjin, China
          Institute of Hematology & Blood Diseases Hospital
        Jun 13, 2023

        CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

        Not yet recruiting
        • CLL/SLL
        • lisaftoclax +BTK inhibitor
        • BTK inhibitor
        • (no location specified)
        Oct 26, 2023

        Lymphoma Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (PNEUMOVAX 23, Fluarix, FluLaval)

        Recruiting
        • Lymphoma
        • PNEUMOVAX 23
        • +9 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 17, 2022

        Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib)

        Active, not recruiting
        • Chronic Lymphocytic Leukemia
        • Chandler, Arizona
        • +107 more
        Mar 8, 2022

        Mantle Cell Lymphoma Trial (Zanubrutinib, Rituximab)

        Not yet recruiting
        • Mantle Cell Lymphoma
        • (no location specified)
        Nov 22, 2022

        Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL), Diffuse Large B Cell Lymphoma (DLBCL) Trial in Manchester,

        Recruiting
        • Chronic Lymphocytic Leukemia (CLL)
        • +7 more
        • Manchester, United Kingdom
        • +2 more
        Aug 11, 2022

        r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase

        Not yet recruiting
        • B-cell Lymphoma
        • Beijing, Beijing, China
          Deparment of Hematology, Peking University People's Hospital
        Aug 9, 2022

        Biological Insights of First Relapsed-refractory Mantle Cell

        Not yet recruiting
        • Mantle Cell Lymphoma
          • Milano, MI, Italy
          • +29 more
          Nov 11, 2021

          Mantle Cell Lymphoma, MCL Trial in United States (Tafasitamab, Lenalidomide)

          Recruiting
          • Mantle Cell Lymphoma
          • MCL
          • Basking Ridge, New Jersey
          • +6 more
          Mar 27, 2023

          Relapsed/Refractory Mantle Cell Lymphoma Trial in Worldwide (Fludarabine, Cyclophosphamide, Brexucabtagene autoleucel)

          Recruiting
          • Relapsed/Refractory Mantle Cell Lymphoma
          • Gilbert, Arizona
          • +40 more
          Jan 6, 2023

          LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

          Not yet recruiting
          • Relapsed Non-Hodgkin Lymphoma
            • (no location specified)
            Sep 19, 2023

            Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell Trial in Whittier (Pirtobrutinib, Ibrutinib)

            Recruiting
            • Chronic Lymphocytic Leukemia
            • +3 more
            • Whittier, California
              Innovative Clinical Research Institute
            Aug 8, 2022